- Presentations
- 3
- Markets
- 1
Lyrica CR is a brand of Pregabalin marketed by Viatris Specialty, with 3 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Pregabalin
- Brand owner
- Viatris Specialty
- Registered in
- United States
- Strengths and forms
- 165 mg extended-release tablet, 330 mg extended-release tablet, 82.5 mg extended-release tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Lyrica CR 165 mg extended-release tabletOral | Viatris Specialty | US FDA | Available on request |
| Lyrica CR 330 mg extended-release tabletOral | Viatris Specialty | US FDA | Available on request |
| Lyrica CR 82.5 mg extended-release tabletOral | Viatris Specialty | US FDA | Available on request |
Equivalent brands
Other brands of Pregabalin.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Lyrica CR
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.